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The isolation and structure of a-corticotropin, a  polypeptide of 39 amino 
acid residues, derived from sheep pituitary glands and possessing an adreno- 
corticotropic (ACTH) activity of 150 I.V.  per rag., have been reported from 
this laboratory (1-3). The present paper is concerned with various biological 
properties of the peptide hormone. 
A. Stimulation of the Adrenal  Glands in Normal  and Hypopkysectomized  Rats 
Experiments  witk Normal Rats.--The increment of adrenal weight in 21-day- 
old normal male rats induced by the administration of ACTH preparations 
has been suggested by Moon (4) as a criterion for the assay of ACTH potency. 
Because various substances and conditions will produce adrenal hypertrophy 
in the intact animal, this criterion is not specific, and hence, as has been dis- 
cussed elsewhere (5),  this type of assay does not furnish a  reliable index of 
degree of biological potency. It is, however, useful for detecting activity in a 
preparation,  since  adrenocorticotropicaUy  active  preparations  should  be 
capable of increasing the adrenal weight in normal animals. 
The hormone peptide was suspended in peanut oil and S per cent beeswax according to 
the procedure described by Bruce, Parkes, and Perry (6). Male rats, 28 days of age, of the 
Long-Evans strain were injected intraperltoneally with 0.1 ml. of the hormone suspension 
once daily for 4 days, and the --|reals were autopsied 24 hours after the last injection. As 
Table I reveals,  1 a daily dose of 1S/zg of a-corticotropin for 4 days produced an increase in 
* Present address: Nordisk Insulin Laboratorium, Copenlmgen,  Denmark. 
Present address: Department of Anatomy, George  Washington University, Washington, 
D.C. 
§ Present address: University of Southern California  School  of Medicine, Los Angeles. 
1  It may also be noted that the gain in body weight during the 4 day injection period de- 
creases as the dosage of a-corticotropin increases. This growth-inhibiting  effect of a-cortico- 
tropin will be discussed on page 343. 
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adrenal weight of nearly 100 per cent, and an 80 per cent reduction of thymus weight. It is 
of interest to note that a dose of 4#g. of the peptide hormone administered daily over a 4 day 
period did not result in any significant change i n  the adrenal weight, whereas the same daily 
dose produced marked reduction of thymus weight. The observation that the involution of 
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TV_~T-FIo. 1. Increment of the adrenal weight as the function of ot-corticotropin dosage in 
immature male rats. 
TABLE  I 
Effect of a-Corticotro >in on the Adrenal Weight of Immature Male Rags 
Daily dose  No. of  rats* 
gg. 
0  34 
4.0  17 
15.0  11 
37.5  38 
75.0  12 
Body weight 
O xset  A~ top., 
gm.  gm. 
644-  3:~  864- 
67  4-  2  83  4- 
66  4-  4  75  -4- 
66  4-  3  72  4- 
604-3  644- 
Adrenals 
mg. 
2  23.5  4-  0.8 
3  25.1  4-  1.3 
3  43.1  -4-  1.7 
2  73.8  4-  2.9 
4  88.9  4-  6.4 
Thymus 
~g. 
240.9  4-  13.7 
134.1  .-I- 14.3 
42.2  4-  3.9 
33.0  4-  1.5 
24.4  4-  2.4 
* 28 day old male rats. 
:~ Mean =t= standard error. 
the thymus gland is a  more sensitive indicator of ACTH activity than is the increment of 
adrenal weight in normal rats is in accord with earlier findings (7, 8). 
It can been seen in Text-fig. 1 that the weight of adrenal glands induced by 
a-corticotropin is a function of the daily dosage of the hormone employed: 
A  ffi  51.3 log D  --  9.4  (1) 
in which A is the adrenal weight in rag. and D the daily dose in micrograms; 
this assay procedure has an index of precision (•)  of 0.31. LI  ET  AL.  337 
Experiments  with Hypophysectomized Rats  (with H. D. Moon and A. Los- 
troh).--Once it had been shown  by Smith (9)  that atrophy of the adrenal 
cortex  follows hypophysectomy of the rat,  and that pituitary implants will 
restore the adrenal cortex, a method was available for measuring the ACTH 
activity of pituitary extracts. The obvious  advantage in using  hypophysec- 
tomized animals for the bioassay of ACTH preparations is that, through the 
removal of the pituitary gland, all so called non-specific effects are eliminated; 
consequently, any effects that are noted can be ascribed wholly to the action 
of the injected material. As early as 1933, Collip et al. (10), proposed an assay 
for adrenal-stimulating substances  using  the  hypophysectomized rat.  Esti- 
mates of potency were to be based on a comparison made between the weight 
TABLE  II 
Effect of a-Corticotropin  on Adrenal and Thymus Weights of Hypophysectomized 
Male Rats 
Daily dose 
0 
1.5 
3.8 
7.5 
15.0 
22.5 
No.  of 
animals* 
21 
4 
9 
8 
11 
11 
Body weight at autopsy 
gin. 
117  4-  2~ 
121  4-  6 
123  4-  4 
120  4-  4 
138  4-  5 
139  4-  6 
Adrenal 
mg. 
11.2  4-  0.2 
15.5  4-  0.7 
20.8  4-  0.6 
23.9  4-  1.1 
29.5  4-  1.4 
31.3  4-  1.3 
Thymus 
mg. 
264  4-  7 
248  4-  13 
110  4-  10 
824-  7 
117  4-  16 
78  4-  10 
* Operated on at 40 days of age; intraperitoneal injections (0.1  ml.), begun 4 days later, 
were administered once daily for 4 days; and autopsy was performed 24 hours after the last 
injection. The hormone was suspended in beeswax-peanut oil. 
Mean 4- standard error. 
of one adrenal removed prior to treatment and the weight of the remaining 
adrenal subjected to  the influence  of the ACTH preparation. Later, other 
investigators (5) employed hypophysectomized rats for the standardization of 
ACTH preparations  on  the  basis  of either partial repair  of the  atrophied 
adrenals, or of maintenance of normal adrenal weight by injections initiated 
immediately after hypophysectomy. 
In the present experiments, male rats of the Long-Evans strain, hypophysectomized at 40 
days of age, were injected intraperitoneaily with ot-corticotropin in beeswax-peanut oil sus- 
pension (0,1 ml.), once daily for 4 days, beginning 4 days after hypophysectomy. Twenty-four 
hours after the last injection, the animals were autopsied; the adrenal and thymus glands 
were dissected and weighed, and the adrenals were fixed in formalin or Zenker-formol. PamJfin 
sections, 7 #  thick, were prepared and stained with hematoxylin and eosin. Frozen sections, 
10/~ thick, were stained with oil-red O and hematoxylin. 
Table II shows the response  of the adrenals to graded doses of a-cortico- 
tropin. It can be seen that a daily dose of 7.5 #g. in 4 days gave a 100 per cent 338  COgT~COTROPmS. X 
increment of adrenal weight over  the  control;  a  straight line  relationship 
exists between the weight of the adrenal glands and the logarithmic function 
of the daily dose as shown in Text-fig. 2. By the method of least squares, this 
relationship may be expressed by the following equation: 
A =  13.7 log Z) +  12.8  (2) 
in which A is the adrenal weight in milligrams and D the daffy dose in micro- 
grams.  The index of precision  (X) was calculated to be 0.26. Thus,  according 
to this equation, a  dose of 5 gg. of a-corticotropin administered once daily 
over a 4 day period would cause an increase in the adrenal weight of hypophy- 
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T~xT-FIo. 2, Increment  of the adrenal  weight as the function  of a-corticotropin dosage  in 
hypophysectomized  male rats. 
sectomized  male rats (40 days old at operation and 4 days postoperatively) 
of from 11.2 to 22.4 rag. As would be expected, the thymus glands of the rats 
treated with a-corticotropin were smaller than those of the controls.  It is of 
interest to note that the reduction of thymus weight is more marked in nor- 
mal rats (Table I) than in hypophysectomized  animals (Table II). 
The microscopic  changes  in the adrenal glands that follow the adminis- 
tration of a-corticotropin can be seen in Figs. 1 through 8. The adrenal cortices 
of the hypophysectomlzed controls were composed of small ceils with  small 
nuclei. The junction between the zona glomerulosa  and zona fasciculata was 
devoid of lipide,  but small amounts of lipide  were present in the remainder 
of the cortex. The cells of the adrenal cortices of the hypophysectomized rats 
injected with a-corticotropin were larger than those of the controls.  Cortical 
hyperemia was manifested by dilatation of  the  sinusoids.  With  the  lower 
dosages, lipide appeared in the cells of the junctional zone;  in addition, the 
large  intracytoplasmic lipide-globules  characteristic  of  the  fasciculata  and LI ~..T AL.  339 
reticularis  of the  hypophysectomized animal  were replaced by fine droplets. 
At higher  dose levels  the  cells  of the  adrenal  cortex increased  progressively 
in size, and there was some decrease in the staining reaction for lipide. These 
histological  patterns  are  similar  to  those  previously  described  by  other  in- 
vestigators  (11)  for ACTH-stimulated  adrenal  glands  of hypophysectomized 
rats. 
B.  E.ffect on the Level  of Circulating  Eosinophils in Hypophysectomised  Rats 
(with G. F. Hungerford and W. O. Reinhardt) 
The level of circulating eosinophils falls within a few hours after stimulation 
of the adrenal  glands or after the administration  of adrenal cortical steroids. 
This phenomenon has been employed as a  basis for the assay of adrenal ster- 
oids  in adrenalectomized  mice  (12)  and  of ACTH in normal  mice  (13).  An 
eosinopenia  has  also  been  reported  following  the  administration  of ACTH 
preparations  to  hypophysectomized rats  (14).  However,  good dose-response 
curves were not obtained with  these  earlier  ACTH preparations  when  they 
were assayed on the basis of eosinopenic response.  Hence,  it was of interest 
to investigate the effect of a-corticotropin in this regard. It  will be seen that 
assays  performed  on  the  basis  of  the  eosinopenic  response  of  hypophysec- 
tomized  rats  to  a-corticotropin  exhibit  satisfactory  dose-response  relation- 
ships below the 10 ug. dose level. 
Eosinophil counts were made daily for the first 5 days after operation on hypophysecto- 
mized male rats of the Long-Evans strain, weighing 200 to 350 gm. If the hypophysectomized 
animals were not used for corticotropin  assay within  2 days after hypophysectomy,  it was 
found necessary to stimulate  the adrenal glands with a single injection of a potent ACTH 
preparation  24 hours before the assays were performed in order to insure responsiveness to 
the effects of the ot-corticotropin. 
All blood counts were made from tail vein blood. The Spiers-Meyer diluent  (15) was used 
for the direct eosinophil counts. A dilution of 1:20 was made and the counts were performed 
on a Fuctm-Rosenthal hemocytometer  0.2 ram. deep, two chambers being counted for each 
sample. An eosinophll count was taken prior to injection of the test substance, and another 
was taken 4 hours later; the change between the two counts was calculated as a percentage 
of the initial value. If an initial count was lower than 100 ecr~nophlls per mm  3 of blood, the 
animal was not used. Total white blood counts were made using a 1.0 per cent acetic acid 
diluent.  A  1:20 dilution was made and counts were performed on a Levy hemocytometer. 
Blood smears were made and stained with Giemsa; between 100 to 200 cells were  counted. 
From these values, the total number of lymphoeytes (mononuclear leucocytes) was calculated. 
The c~-corticotropin samples were dissolved in a 0.9 per cent saline solution, and a crystalline 
suspension of hydrocortisone acetate (Merck) was used for comparative assay. Control ani- 
mals received a 0.9 per sent saline solution alone. All injections were given intraperitoneally. 
Table III presents  the percentage of change in eosinophil counts after the 
administration  of  graded  doses  of  two  preparations  of ~-corticotropin.'  A1- 
Preliminary  experiments indicate  that a-corticotropln  does not exhibit  an eosinopenic 
effect in bypophysectomized-adrenalectomized rats. 340  CORTICOTROPIlqS.  X 
though higher doses were given, the response was found to be maximal at the 
10 gg. dose level. The dose-response curve could be plotted as a  straight line. 
It is also interesting to note that a-corticotropin at a  dose level of 2 ttg. is as 
effective in drepressing  the  number  of circulating eosinophils as  100  #g.  of 
hydrocortisone in crystalline suspension. 
When  the  effect of a-corticotropin on  the number  of circulating lympho- 
cytes was investigated at one dose level (100 #g.),  the total number of blood 
TABLE III 
Effects of ot-Corticotropin and Hydrocortisone on Blood Eosinophils of Hypopkyseaomized 
Rats 
Test substance  Dose  No. of rats  Change in  eosinophil levels 
ot-Corticotropin (CC4Ht-D) ............. 
Saline ................................ 
,v-Corticotropin (CC8Ht-2) .............. 
Saline ................................ 
Hydrocortisone  ........................ 
//,g. 
10 
7 
5  ~ 
3 
1 
0.5 cc. 
5.0 
3.5 
2.0 
0.5 
0.5 cc. 
1000 
250 
100 
8 
6 
9 
9 
10 
19 
12 
13 
19 
6 
22 
10 
9 
10 
~¢r con| 
--89 4-  5* 
--85:/=  3 
--764-  3 
--51  4-  10 
--23  4-  8 
--24.  5 
--704-  6 
--54=1=  13 
--41  ±  10 
--25  4-  10 
84-7 
-95  4-  2 
--824-  8 
--39 -4-  13 
* Mean -4- standard error. 
lymphocytes was found to be significantly decreased (--44 4- 5 per cent in 9 
rats as compared with -t-38 4- 16 per cent in 5 rats of the saline control group). 
C. Effect on the Muscle Glycogen of Hypopkysectomized Rats 
(with P. Fenss-Bech) 
In  earlier investigations,  no  effect with  respect  to maintenance  of muscle 
glycogen in hypophysectomized animals was found to be exercised by ACTH 
concentrates  (16,  17).  However, it will be seen that a-corticotropin is highly 
active in this respect in fasted hypophysectomized animals. 
Male rats of the Long-Evans strain, weighing 280 to 300 gin., were hypophysectomized 
2 weeks prior to the experiment. Some were adrenalectomized  in addition, 5 days prior to the L1  zT  AL  341 
experiment; the doubly operated animals were  maintained with daily injections d  either 0.5 
rag. of hydrocortisone acetate or 1.0 rag.  of desoxycorticosterone  acetate per animal. All 
animals Wexe  fasted for 24 hours before autopsy, and the ot-corticotropin, as a beeswax-peanut 
oil suspension,  was  administered intraperitoneally 16 hours  prior to  sacrifice.  Analytical 
procedures were similar to those described by Russell and Wilhelmi (18). 
TABLE IV 
Effect of o~-Corticotropin on Muscle Glycogen of Hypophysectomized Male Rats Fasted  for 24 
Hours 
Muscle glycogen 
Dose* 
Without  hydrocorfisone  With hydrocortisone$ 
0 
1.5 
7.5 
37.5 
rag.  per c~t 
278  4-  9.7  (5)§ 
307  4-  14.4  (5) 
370  4-  17.0  (5) 
405  4-  11.1  (5) 
rag.  per cent 
414  -4-  19.9  (5) 
464  +  11.6  (4) 
$59  q- 29.6  (4) 
588  q- 34.1  (4) 
* Dose per 100 gm. body weight. 
0.I rag. hydrocortisone acetate injected daily for 7 days prior to sacrifice. 
§ Mean -4- standard error (No. of rats). 
TABLE V 
Effect of a-Corticotropin on Muscle Glycogen of Hypophysectomized-Adrenalectomized Rats 
Fasted  .for 24 Hours 
Muscle glycogen 
Dose* 
Hydrocortisone$  Desoxycorticosterone~ 
~g.  rag.  per cent  rag. per cent 
0  453  -4- 29.3  (4)[[  683  q-  18.8  (9) 
50  426  q- 41.7  (5)  625  -4-  17.0  (9) 
* Dose per 100 gin. body weight. 
Daily doses of 0.5 mg. hydrocortisone acetate begun on the day of adrenalectomy and 
administered for 5 days prior to sacrifice. 
§ Daffy doses of 1.0 rag. desoxycorticosterone  acetate begun on the day of adrenalectomy 
and administered for 5 days prior to sacrifice. 
[[ Mean q- standard error (No. of rats). 
Inspection of the data, presented in Table IV, obtained with hypophysec- 
tomized rats  shows  that  without  hydrocortisone, a-corticotropin in  a  single 
dose of 7.5 #g. per 100  gin.  body weight prevents significantly a  decrease of 
muscle glycogen. When  the animals were pretreated with 0.5  rag.  of hydro- 
cortisone daily for 7 days before sacrifice, the dose of a-corticotropin required 
for an increment of the muscle glycogen is much smaller; namely 1.5 #g. This 
may  be  taken  to  mean  that  the  presence  of  hydrocortisone  enhances  the 
myoglycostatic effect of a-corticotropin. It may be noted further  that,  with 342  CORTICOTROPnCS. x 
or without  pretreatment  with  hydrocortisone,  the  level of muscle glycogen 
is elevated in proportion to the increase in the dosage of a-corticotropin. In 
rats  that  were adrenalectomized as well,  the  peptide  hormone was without 
effect (Table V). It is of interest  to note that  the steroid hormones  (hydro- 
cortisone and desoxycorticosterone) used for maintenance of the latter animals, 
themselves caused an elevation of the muscle glycogen levels of both hypophy- 
sectomized and hypophysectomized-adrenalectomized rats (Tables IV and V). 
Earlier studies have shown that corticosterone and cortisone, as weU as crude 
cortical extract,  are capable of preventing the depletion  of muscle glycogen 
in rats after hypophysectomy (16, 19, 20). 
TABLE VI 
Antagonism between  ot-Corticotropin and Soraatotropin as Evidenced by Tibia Test 
Group* 
Control ......................... 
Somatotropin .................... 
ot-Cortieotropin$  ................. 
Somatotropin +  ot-Corticotropin~.. 
~t-Cortieotropin§ ................. 
Somatotropin +  ~-Corticotropin§.. 
Total dose 
0 
60 
10O 
60+  10O 
10O 
60+100 
Width of 
uncalcified 
cartilage plate 
163 
244 
148 
251 
116 
126 
A&enals 
mg. 
7.9 
8.3 
11.8 
12.4 
19.3 
20.9 
Thy,,,tm 
mg. 
164 
176 
87 
109 
44 
44 
* 10 animals per group. 
Administered intraperitoneaily in aqueous solution. 
§ Administered subcutaneously in peanut oil-beeswax suspension. 
D. Effect on Growth in Hypophysectomized and 
Hypophysectomized-Gonadectomized Rats 
The early observation of Moon (21) on the retardation of the somatic growth 
of young  castrated  male rats  by  crude  ACTH preparations  has  been  con- 
firmed by various investigators  (22)  using partially purified  ACTH concen- 
trates. It is now known that a-corticotropin is a  potent growth inhibitor,  as 
evidenced  by  its  antagonistic  action  to  the  growth-promoting  activity  of 
somatotropin  (growth  hormone)  in  hypophysectomized  and  hypophysec- 
tomized-gonadectomized rats. 
Effect on the Tibia (with I. I. Geschwind).-- 
Hypophysectomized female rats of the Long-Evans strain (26 to 28 days of age at opera- 
tion), were injected 12 to 13 days postoperatively, once dally for 4 day~. Twenty-four hours 
after the final injection, the animals were autopsied, the tibias excised, and the uncaleified 
portion of the proximal epiphyseal cartilage of the tibia was stained with silver nitrate  as 
previously described (23). In some experiments, the ot-corticotropin was mixed with somato- 
tropin  (isolated from anterior lobes of bovine pituitaries by the published method (24)) in LI ~.T AL.  343 
aqueous  solution which was then administered intraperitoneally, and in others, the peptlde 
hormone alone was injected subcutaneously in beeswax-peanut oil suspension. 
The  results are summarized in Table VI;  these experiments have  demon- 
strated  that  in  aqueous  solution,  very high  doses of a-corticotropin, either 
alone or in conjunction with growth hormone,  had little effect on the width 
of the tibial cartilage, despite the fact that significant involution of the thymus 
did occur. When administered in a  delaying medium, namely, beeswax-peanut 
oil,  a-corticotropin causes  a  very  marked  thymic  involution,  a  greater  in- 
crease in adrenal weight, a  highly significant decrease in the control cartilage 
width, and an almost complete inhibition of the response to growth hormone. 
Effect on Body Growth (with T. Hayashida).-- 
TABLE VII 
E~ect of a-Corticotropin, Somatotropin and Their Combination on Adrenal, Thymus, Spleen, 
and Body W¢igkts of Hypophysectomized.Ovariectorained Rats 
Experiment* 
Control ...... 
$omatotropin... 
~-Corticotropin. 
$omatotropin... 
+ 
~-Corticotropin. 
Daffy 
dose 
rag. 
0 
0.300 
0.018 
0.300 
+ 
0.018 
Body weight 
Onset  Autopsy  Changes 
gm.  gra.  gm, 
135.0  134.0  --1.0 
136.0  160.3  +24.3 
141.0  129.5  --11.5 
140.0  139.1  --0.9 
Adrenal 
rag. 
8.3 
13.4 
28.7 
29.9 
Thymus 
rag. 
208 
418 
Nil 
Nil 
Spleen 
rag. 
501 
652  " 
251 
450 
* Female rats (45 to 50 days old) hypophysectomized 2 days after ovariectomy; injec- 
tions begun 5 days after hypophysectomy and continued daffy for 10 days; 7 animals in 
each group. 
Female rats of the Long-Evans strain were  ovariectomized  at the age of 48  days and 
hypophysectomized 2 days later; subcutaneous daffy injections of a-corticotropin (18/zg.) 
and growth hormone (300 #g.) were begun 5 days after hypophysectomy and were continued 
for 10 days. The animals were maintained on a standard enriched diet  s in dry powder form, 
3 Di,  t composition:  per cent 
Ground whole wheat ...............................................  67.5 
Casein, tech ......................................................  15.0 
Skim milk powder .................................................  7.5 
Sodium chloride  ...................................................  0.75 
Calcium carbonate  .................................................  1.5 
Melted fat (hydrogenated vegetable oil) ..............................  6.75 
Fish oil (sardilene) 750 units vitamin A and 300 units vitamin D per gin:)...  1.0 
Approximate composition:  per cent 
Protein ...........................................................  24.5 
CHO .............................................................  54.9 
Fat ..............................................................  8.9 
Sufficient KI solution is added to furnish 0.9 #g. of iodine per gm. of diet. 344  CORTICOTROPINS.  X 
given ad libitum.  They were weighed every 2nd day, and autopsy was performed 24 hours 
after the last injection. Growth hormone was administered subcutaneously in aqueous solution 
and ¢x-corticotropin  was given in the form of a 5 per cent beeswax-peanut oil suspension. 
It can be seen from Table VII and Text-fig. 3 that the animals given a-cor- 
ticotropin alone lost 11 gin. of body weight in 10 days, whereas the controls 
lost  1 gin.  during the  same period.  The animals treated with somatotropin 
alone gained at the rate of about 2.5 gm. per day. When c~-corticotropin was 
administered  together  with  somatotropin,  the  growth-promoting  effect  of 
the htter was almost completely neutralized by a daily dose of 18 #g. of the 
+24  e--e Contro! 
o-o a-cot  ticofropin  ~/" 
~C  ~  Somatotropin 
~--¢:~  ~~  Combination 
~.  IE  • 
..c 
._~ ]2 
>, 
o  4 
m 
o  I  star~ed  ~ 
0  -:8  I  I  |  I  I  I  I  I  i  i 
0  I  2  3  4  5  6  7  8  9 
Doys  of  Injection 
TExT-Fzo.  3.  The  influence  of a-corticotropin  on  body  weight  of hypophysectomized- 
ovariectomized rats. Daily dotages: o~-corticotrop~n, 0.018 rag.; somatotropln, 0.300 rag. The 
body weight of the rats in all experimental groups at beginning of injections is in the range 
of 137 to 141 gm.; 7 rats per group. 
former.  In each of the groups, treated with a-corticotropin or with a-cortico- 
tropin plus somatotropin, complete involution of the thymus gland was noted. 
It is of interest that not only is marked involution (50 per cent) of the spleen  4 
produced  by  the  administration  of a-corticotropin  at  18  #g.  per  day,  but 
also the usual stimulating effect exercised  by growth hormone on the spleen 
is counteracted by the simultaneous injection of a-corticotrophin. 
E. Melanocyte-Stimulating  Activity of a-Corticotropin 
(with I. I. Geschwind) 
In previous publications from this laboratory (25, 26) it has been demon- 
strated  that  most  of  the  melanocyte-stimulating  activity  found  in  crude 
4 The histological  changes  produced  in the spleen and adrenal  glands by the combined 
effect of somatotropin and a-corticotropin will be reported elsewhere. ZI  ET  AL.  345 
corticotropin  concentrates  can  be  separated  from  the  adrenal-stimulating 
activity by chromatographic and  electrophoretic methods.  For example,  in 
one of the steps in the procedure for the isolation of a-corticotropin (2) these 
two activities are resolved in the main during chromatography on the XE-97 
cation exchange column, where the activity associated with the melanocyte- 
stimulating  hormone  (MSH;  intermedin)  passes  through  the  column unre- 
tarded.  Hence,  there  seems little  question  that  MSH  is  not  identical with 
corticotropin. It was also pointed out, however, that it had not been found 
possible  to  separate  completely  the  melanocyte-stimulating  activity  from 
the corticotropic activity in ACTH preparations.  Moreover, the association 
between these two activities has persisted in the pure corticotropin prepara- 
tions  obtained  by  means  of  the  countercurrent  distribution  procedure.  A 
TABLE VIH 
Mdanocyte-Stimulating  Activity of ot-Corticotropin Preparations 
Preparation  No. of assays*  Activity 
8HP2 
10H"B,,-D 
21H~B  ,, 
34HIB,, 
42H~'Br.D 
52H"B2-D 
55H~B,~-D 
unlts/gm. 
0.24 X  IO  s 
1.01 X  10  s 
0.80 X  108 
0.64 X  10  8 
0.28  X  10  s 
0.40 X  l0  s 
0.80  X  10  s 
* Each assay was performed on 2 to 4 pieces of frog skin at 2 different dose levels. 
number of such preparations have been extensively assayed by the method 
of Shizume et al. (27), with isolated frog skin used as the substrate. The results 
of  these  assays,  presented  in  Table  VIII,  indicate  that  activities  ranging 
from 0.25 to 1.0 X  108 units per gram  5 were to be found in all preparations 
tested, with an average activity of 0.60 X  10  s units/gm. The variable activity 
observed is,  in  all  probability,  due  to  a  partial  inactivation which  occurs 
during the countercurrent distribution process. 
It has also been reported (25, 26) that brief treatment of crude corticotropin 
preparations  with  alkali  at  elevated  temperatures  effects a  potentiation of 
their melanocyte-stimulating activity at the same time as a  pronounced loss 
of their adrenal ascorbic acid-depleting activity. To determine the potentiat- 
ing effect on a-corticotropin of treatment with alkali, the hormone was heated 
for 5 to 10 minutes in a boiling water bath, in a solution which was 0.1 N with 
respect to NaOH. Multiple assays with preparations 42H~B~-D and 52HPB2-D 
demonstrated a threefold potentiation of activity to have taken place. 
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a-Corticotropin  is  derived  from  sheep  pituitaries;  the  ovine melanocyte- 
stimulating hormone has not as yet been isolated and little is known regarding 
the effect of alkaline heat treatment  on the intermediate  lobe hormone de- 
rived  from  this  species.  Moreover,  no  generalizations  from  one  species  to 
another can be made since porcine MSH is not potentiated by alkali whereas 
the bovine hormone  is  (28).  Consequently,  in  the absence  of any data  on 
sheep MSH, the activity of a-corticotropin  can only be compared with the 
sole MSH that has been thoroughly studied; i.e.,  the porcine hormone.  The 
specific activity of the latter hormone (29) is 100 or more times  more active 
as  a  melanocyte stimulator  than  is a-corticotropin.  Nevertheless,  the  high 
and  comparatively  constant  melanocyte-stimulating  activity  present  in 
a-corticotropin preparations reinforces the probability that  it is an inherent 
activity of this hormone. The probable basis for this effect, in terms of chemi- 
cal structure, has recently been presented (29). 
F. Fat-Mobilizing  (Adipokinetic)  Activity of ~-Corticotropin 
(with I. I. Geschwind and M. Sideman) 
It has been known for about 20 years that injection of extracts of the an- 
terior pituitary gland causes an increase in liver lipides,  by mobilizing  lipide 
from the body depots (30).  Early experiments on  the effects of injection of 
crude corticotropin preparations have been summarized by Levin and Farber 
(31),  who  were of the opinion that  growth hormone,  and not corticotropin, 
was  the  pituitary  factor  involved.  Recently,  Rosenberg  (32)  demonstrated 
that oxyceUulose-purified  corticotropin concentrates possessed marked adipo- 
kinetic activity.  However, since  the effect was discernible in the adrenalec- 
tomized animal  (maintained  on  steroid  therapy),  confirming  a  finding  first 
reported by Payne (33),  Rosenberg suggested that  the activity might reside 
in a  contaminating  adipokinin,  rather  than  being  an extra-adrenal  function 
of the corticotropin molecule. 
The adipokinetic activity of a  number of hormones has been determined 
over a period of several years in this laboratory. All results suggest that adipo- 
kinetic activity  6 is shared  by a  number of different hormones,  and  in each 
case responds to chemical or enzymatic modification in the same way as the 
characteristic activity of the hormone in question, suggesting  that there exist 
many  different  "adipokinins."  Herein  is  reported  the  data  concerned  with 
the adipokinetic activity of a-corticotropin. 
Adipokinetic activity was measured according to the procedure of Campbell (34). Virgin 
female mice (Swiss white) weighing 17 to 20 gin. were fasted for 7 hours. All preparations 
6 Adipokinetic activity refers to the ability to increase the amount of fat in the liver within 
a  short period of time. How  this is accomplished--by mob'fli~tion of fat from depots,  by 
decreased oxidation or by increased lipogenesis--is not taken into account, nor is the chemical 
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(in beeswax-peanut off suspension)  were administered intraperitoneally at the beginning  of 
the period of fast and the animals were sacrificed 7 hours later. Their livers were then re- 
moved, washed, and freeze-dried. Liver lipides were determined by a modification (32) of the 
procedure of Folch eta/. (35). 
The results obtained with a  typical corticotropin preparation are presented 
in Table IX. It may be seen that as little as 0.5 ~g. elicits a  highly significant 
increase in liver lipide during a  7 hour fast.  Furthermore,  it is evident that a 
positive correlation exists between the dose of hormone administered and the 
amount of lipide in the fiver. By way of comparison, it has been found that 8 
to  16 times as much  of growth hormone is required to produce a  similar re- 
sponse. 
In order to find out whether or not the adipokinetlc effect of corticotropin can still be 
observed in the absence of the adrenals, a series of experiments  was performed on animals 
TABLE IX 
Adlpokineti¢ Effect of et-Corticotropin in Fasted Mice 
Dose  No. of animals  Amount of fat in fat-free dry liver* 
0 
0.5 
2.5 
10.0 
27.6  -4- 2.5:l: 
39.9  .4- 2.7 
52.0  -4- 2.5 
58.4  .4-  4.4 
*  Weight of total lipide 
X  100. 
Weight of dry liver -- weight of totsl lipide 
$ Mean -4- standard error. 
adrenalectomized  3 days prior to the experiment.  Some of these animals received no main- 
tenance therapy with sterioids, while others were maintained with daily subcutaneous  injec- 
tions of 0.1 to 0.2 nag. of hydrocortisone acetate. All operated animals were fed a diet of bread 
and milk, and saline solution.  The results of experiments employing such animals confirmed 
(Table X) the findings of Payne (33), Levin and Farber (31), and Rosenberg (32) that cortico- 
tropin preparations show no adipokinetic effect in adrenalectomized  animals not maintained 
with cortical hormones. On the other hand, maintenance of such animals with adrenal ster- 
oids permitted the development of an adipokinetic effect. In no case, however, was the re- 
sponse as great in the maintained adrenalectomized  animal as it was in the normal animal. 
Thus,  the  adipokinetic effects  demonstrated  by  more  crude  preparations 
have also been observed in pure a-corticotropin, a  hormone whose  structure 
has been  established  (3).  However,  since there would  still seem  to be  some 
question  as  to  whether  the  adipokinetic activity is  inherent  in  the  cortico- 
tropin  molecule,  a  series  of  experiments  was  performed  with  corticotropin 
preparations that had been submitted to peptic and chymotryptic hydrolysis. 
It  has  been  previously  demonstrated  (3,  36)  that  limited  digestion  with 
pepsin alters very little the adrenal-stimulating function of corticotropin. On 348  CORTICOTROPINS.  X 
TABLE X 
Eff~t~Adr~ectomyon  Adipok~et~ Aetion~a-C~ticotroplnin  Fast~M~e 
Experiment  Animals*  Dose  .  No. of animals  Amount dry°f  fatliverin  fat-free 
II 
N 
N 
A 
A§ 
A§ 
N 
N 
A 
A§ 
A§ 
0.5 
0.0 
0.5 
#g. 
0.0  12 
0.5  8 
4 
12 
5 
per ~nl 
34.5  4-  2.6~ 
45.0  4-  2.8 
36.1  4-  5.0 
34.1  4-  2.9 
40.7  4-  5.8 
0.0 
1.5 
1.5 
0.0 
1.5 
33.7  4-  2.6 
57.4  4-  4.6 
32.1  4-  2.3 
33.8  4-  1.3 
50.1  4-  1.3 
* N, normal; A, adrenalectomized. 
~t Mean 4- standard  error. 
§ Maintained  with 0.1 to 0.2 rag. of an aqueous suspension of hydrocortisone  acetate per 
day for 4 days. 
TABLE XI 
Effect of Limited Peptic and Chymotryptic Digestion on Adipokinetic  Activity of 
a-Corticotropin 
Experiment 
II 
Treatment 
None 
Pepsin* 
None 
Chymotrypsin:~ 
Dose 
~g. 
0 
20 
20 
50 
0 
50 
20 
50 
NO. of 
animals 
Amount of fat in fst-free 
dry liver 
per ¢¢nl 
38.2  4-  1.8 
71.5  4-  5.8 
47.7  4-  2.7 
68.04-  2.7 
30.0  4-  1.9 
74.8  4-  6.2 
34.5  4-  3.3 
37.4  4-  4.6 
* Hydrolyzed  with pepsin  (ratio  of enzyme/substrate by weight  =  1:300) for 2 hours 
at 25°C. 
:~ Hydrolyzed  with chymotrypsin  (ratio  of enzyme/substrate by weight  =  1:300) for 3 
hours at 25°C. 
the other hand, even limited chymotryptic digestion results in an extensive loss 
of such activity. The results presented in Table XI demonstrate that  limited 
digestion  with  pepsin  alters  the  adipokinetic  activity  of  corticotropin  only 
slightly--proportionately to  the  small decrease in  the  adrenal  ascorbic acid- ~I ET AL.  349 
depleting  activity.  On  the  other  hand,  chymotryptic  digestion  abolishes 
almost  entirely both the adipokinetic and  ascorbic acid-depleting  activities 
of corticotropin. 
It is interesting to compare these results with unpublished data on the effect 
of enzymatic digestion on the adipokinetic activity of growth hormone prep- 
arations. When conditions of digestion identical with those reported above are 
employed, it has  been found  that  an  almost  complete loss of adipokinetic 
activity occurs following treatment with pepsin, whereas chymotryptic diges- 
tion leaves this activity intact. In the case of this hormone, it has been previ- 
ously established (37)  that peptic digestion causes complete loss of growth- 
promoting  activity,  whereas  limited  chymotryptic  digestion,  such  as  that 
employed here,  has very little  effect on the functions of the hormone  as a 
growth  stimulator.  Thus,  the  adipokinetic  activities  in  a-corticotropin  and 
in growth hormone respond in an opposing fashion to treatment  with these 
two enzymes; this furnishes a  further  illustration  of the observation, noted 
above, that when a  hormone is subjected to chemical treatment,  the adipo- 
kinetic activity varies in accordance with the major activity associated with 
that particular hormone. 
The entire body of these results support the contention that an adipokinetic 
function  is  an  inherent  activity of  corticotropin.  The  hormone  apparently 
serves a  dual  purpose  by first  stimulating  the  adrenal  to  secrete steroids, 
which then serve as"permissive" agents to potentiate the extra-adrenal adipo- 
kinetic effect of the hormone. 
G.  Effect  on  the Accessory Sex  Glands of Castrated Hypopkysectomized  Rats 
(with A. Lostroh) 
Davidson and Moon (38) were the first to report that crude ACTH prepara- 
tions  stimulated  the release of androgen(s)  from the adrenal  glands  of  im- 
mature Long-Evans male rats, as evidenced by the growth of the sex  acces- 
sories of castrated animals.  Under these same conditions, no stimulation was 
observed  in  castrated-adrenalectomized  animals  (39),  demonstrating  that 
the effect was not an extra-adrenal one but was mediated through the adrenal 
glands.  Although Nelson confirmed these findings  (40),  the negative reports 
found in the later literature suggest that this stimulation may not be produced 
by more purified ACTH preparations (41).  Recently, we have reinvestigated 
this  problem in hypophysectomized-castrated male  rats  of the Long-Evans 
strain and have found that ACTH is the only pituitary hormone that is directly 
responsible for the androgen production (42). Inasmuch as the ACTH prepara, 
tion used in  the earlier investigation could be further  purified,  it remained 
to be determined whether or not similar results could be demonstrated with 
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Male rats of the Long-Evans strain were castrated  at 43 days of age and hypophysec- 
tomized at 44 days. Some of the animals were also adrenalectomized; these animals were 
maintained on 1 per cent NaC1 solution. For the triple operation, the testes and the right 
adrenal were removed at 43 days, and the left adrenal was removed on the 46th day. Twenty- 
four hours  after  the final operation,  a  regimen of single daffy subcutaneous injections of 
a-corticotropin in a 5 per cent beeswax-95 per cent peanut oil medium was initiated. On the 
day following  the tenth injection, the animals were anesthetized with nembutal; the adrenals, 
ventral prostate,  and seminal vesicles were removed and weighed. The sex accessories were 
immediately  fixed in neutral formalin, and were subsequently  sectioned by the  paraffin 
method, and stained with hematoxylin-eosin. 
TABLE XII 
Effect of a-Corticotropin  on the Weights of Sex Accessories o] Hypophysectomized-Castrated 
and Hypopkysectomized-Castrated-Adren~ectomized  Male Rats 
Animah*  Treatment 
I-C  Saline 
"  a-Cortico- 
tropin 
I-C-A  DOCA§ 
"  ce-Cortico- 
tropin 
"  ot-Cortico- 
tropin + 
DOCA 
Daily 
dose 
#g. 
0 
15.0 
22.5 
I00.0 
22.5 
22.5  + 
100.C 
No.  of 
rats  " 
Body 
weights 
On-  Au- 
set  tops~ 
gin.  gin. 
122  120 
119  102 
114  99 
111  114 
112  101 
106  113 
I 
i 
Adrenals 
rag. 
8.8  -4-  0.35 
27.6 -4- 4.7 
53.2  -4- 5.0 
0 
0 
Ventral  Seminal 
prostate  vesicles 
mg.  mg. 
11.6 :i=  1.2  12.3  =i=  1.~ 
14.8  -4- 4.7  19.5  -4- 5.4 
15.8  -4-  1.8  13.9  -4- 0A 
12.3  -4-  1.6  11.5  -4- 0.; 
9.2  =t:  2.0  11.9  :t= 0.( 
11.0 -4-  1.1  11.9  -4- 0.2 
* All animals castrated  at 43 days, hypophysectomized at 44 days and sacrificed at 55 
days.  H, hypophysectomized;  C, castrated;  A, adrenalectomized. 
Mean -4- standard error. 
§ Desoxycorticosterone acetate injected as a sesame oil solution. 
The  results  summarized  in  Table XII  demonstrate  that  a-corticotropin 
given at a  level of 22.5 gg. per day can effect a  slight increase in the  weight 
of  the ventral prostate  of  the  hypophysectomized-castrated male rat in the 
presence of the adrenal glands, but not in their absence. No consistent change 
was observed in the weight of seminal vesicles. While the weight increase in 
the ventral prostate of the hormone-treated group was not significantly  greater 
than that of the saline-treated control (0.1 >  p  >  0.05), a definite histological 
improvement accompanying this  increase  was  apparent  in  all  the  animals 
injected with 22.5 #g. of a-corticotropin. The degree of stimulation evidenced 
by the height of  the  glandular epithelium is illustrated in the  photomicro- 
graph shown in Fig. 9. A daily dose of 15 #g., which produced adrenal weights 
comparable to those of non-hypophysectomized animals, induced no evidence 
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H.  Evidence  for  tke  Secretion  of  Progestogens  by  a-Corticotropin-StimuIated 
Adrenal  Glands 
(with W. R. Lyons) 
It was reported earlier from this laboratory (43)  that highly purified prep- 
arations of ACTH are capable of causing deciduoma formation in hypophysec- 
tomized-oophorectomized rats. This was taken to indicate that ACTH-stimu- 
lated  adrenals  secrete  progestogens  which  are  in  turn  responsible  for  the 
formation of deciduomata. These observations have now been confirmed with 
the pure peptide hormone, a-corticotmpin. 
Female rats of the Long-Evans strain were hypophysectomized and oophorectomized at 
30 days of age; daffy injections of a-corticotropin suspended in 5 per cent beeswax in peanut 
TABLE XIII 
Effez~ of ol-Corticotropin on D~iduoma Formation in Hypophysectomized~Oophoreclomized 
Rats 
Experiment 
Control 
I 
H 
No. of rats 
27 
Daily dose 
~g. 
0.0 
7.5 
22.5 
75.0 
75.0 
Adrenals 
mS. 
8.6 
21.1 
32.1 
68.3 
96.0 
G 
Deciduoma 
Histo 
o~. 
gi ~1  vqmae 
1 
2 
2 
0 
oil were begun on the day of operation and continued for 7 days. On the 3rd day, the uteri 
of all the animals were threaded and necropsy was performed on the day following the final 
injection. Uteri that did not show discrete gross tumors at the thread  sites were studied 
histologically and graded on the basis of stromal cell hypertrophy. 
A  summary of the results can be seen in Table XIII. Two preparations of 
a-corticotropin were employed; at a  daily dose level of 75 ~g. both induced 
small but positive deciduomata in the gross. Groups that received daily doses 
of 7.5  #g. and 22.5 ~g. showed only slight uterine swelling around the thread 
sites; but endometrial sections showed beginning deciduomal reactions in the 
form of enlarged stromal cells in some of these animals. 
Some of the rats receiving one of the a-corticotropin preparations showed 
open vaginae at necropsy, although  they had been oophorectomized on the 
30th day. There was no assurance that this was an effect of an adrenocortical 
estrogen, since the vaginae were studied  only after 7 days of treatment.  At 
that time the epithelium was lightly mucified, but not cornltied. 
In  summary it  may be  said  that  an  adrenocortical  progestogen may be 352  CORTICOTROPINS.  X 
detected in rats in which a  hyperadrenocortical state has been induced with 
a-corticotropin.  The development of deciduomata  under  the  influence of a 
progestogen seems all the more remarkable because at the  same  time other 
corticoids known  to  be  inhibitory  to  progestogen  (e.g.,  cortisone)  are  also 
formed in and secreted by the abnormally enlarged and overstimulated ad- 
renals. 
I. Corticotropin  as a Galactopoietic Hormone 
(with W. R. Lyons) 
In  the  reviews by Folley and  his  colleagues  (44-46)  and  by Mayer and 
Klein  (47)  the importance of the adrenocortical  hormones in  lactation has 
been stressed. The need in lactation for one or another of the adrenal steroids in 
the absence of the pituitary or the adrenal, and for ACTH in the absence of 
the pituitary, has clearly placed ACTH by the side of lactogenic hormone as  a 
galactopoiefic  hormonc  a  substance  that  increases  the  milk yield of an 
animal already lactating (48, 49). 
In our first experiments on replacement therapy in hypophysectomized rats 
an abundant milk secretion was induced by giving a crude lactogenic prepara- 
tion containing enough ACTH to maintain the adrenal cortices and enough 
somatotropin to permit body weight increase in the test rats  (50). However, 
even though the glands were filled with milk and active suckling was observed, 
starvation of the young still occurred, presumably because there was insufficient 
oxytocin to permit milk ejection. Until  recently, pure ACTH has not  been 
available in large enough quantities for testing its galactopoietic potency, and 
it has been more practicable to use the adrenocortical steroids (51-55). The 
availability  of a-corticotropin has  now  permitted  us  to  establish  that  this 
hormone is as important as lactogenic hormone in milk secretion. 
Long-Evans rats bred for the first time at 21/~ to 3 months of age were hypophysectomized 
11 days after the detection of sperm; and, following  delivery, were injected daffy subcutane- 
ously with different levels of a-corticotropin in  beeswax and peanut oil. A potent sheep 
lactogenic hormone preparation (56) containing approximately  30 I.zr. per rag., no detectable 
ACTH or thyrotropin, and not more than 0.5 per cent somatotropin activity was adminis- 
tered in daily subcutaneous injections at the 5 rag. level, alone and in combination with 
a-corficotropin. Injections were continued for the first 10 days after delivery; and necropsies 
were performed  on the 11th day. The weight of the left adrenal was ascertained at necropsy, 
and m~mmary glands were fixed and studied after staining in aium-carmine  and clearing in 
methyl salicylate. 
The test animal used in this experiment was usually found to secrete a small 
amount of milk for a day or 2 after delivery, apparently because of lactogenic 
substance released from the placenta before parturition (53). But by the 11th 
postpartum day the glands of 3 of the uninjected hypophysectomized controls 
were found to be regressing and devoid of milk in the gross (see Table XIV), as LI  ET  AL.  353 
were the glands of the rats that received only a-corticotropin. The rats injected 
with lactogenic hormone alone manifested partial maintenance of their lobulsr 
structure, but secreted less than the small amount of milk seen on the day of 
parturition  in uninjected animals.  All the animals given 5  rag.  of lactogenic 
hormone daily plus 25, 50, or 100 7 of a-corticotropin  showed well-developed 
glands filled with milk. Only the 100 7 dose of a-corticotropin stimulsted the 
adrenals to the degree observed in normal rats at the end of pregnancy.  In 
order to quantitate the efficiency of lactogenic hormone and ACTH as galacto- 
poietic agents, it will be necessary to test them in a complete nursing program 
with the addition of somatotropin, oxytocin, and possibly thyrotropin. 
TABLE XIV 
Galactopoietic E ffec~ of c~-Corgcotropin in Combinagon  ugtk Lactogenic Hormone in Rats 
No. of rats 
3 
3 
3 
3 
3 
3 
35 
a-Corticotropin 
25 
25 
50 
100 
0 
0 
0 
Lsctogenic 
hormone 
mg, 
o 
5 
5 
5 
5 
o 
o 
Left adrenal 
m&. 
14.6 
19.0 
16.6 
45.3 
13.1 
10.7 
40.2 
Milk 
secretion 
1 
+ 
+ 
+ 
(±)* 
+ 
* Slight residual secretion in a  few scattered small lobules. 
Normal rat on 1st postpartum day. 
DISCUSSION 
The various methods that have been advanced for the estimation of adrenal° 
stimulating  activity are generally derived from the manifestations of either 
direct or indirect effects of ACTH on normal or hypophysectomized animals. 
The direct effects are primary; that is, they follow directly from the hormone 
administration  without  the  intervention  of  adrenal  cortical  steroids.  They 
include depletion of adrenal ascorbic acid, hypertrophy of the adrenals,  and 
repair of the histological  changes in the adrenals produced by hypophysectomy. 
The indirect effects are those that result from the formation and release of the 
adrenal cortical steroids following  the administration of ACTH; they include 
eosinopenia,  lymphopenia, involution of thymus and spleen,  and inhibition of 
body growth.  All of these effects have now been shown to  be properties of 
a-corticotropin.  Moreover,  the  peptide  hormone  is  capable  of  maintaining 
muscle glycogen in hypophysectomized rats and of mobilizing fat into the liver 
of fasted mice. 
In both normal and hypophysectomized rats, the increment of adrenal weight 354  CORTICOTROPINS.  X 
produced by a-corticotropin (administered in a beeswax-peanut oil suspension) 
is directly proportional to the logarithmic function of the daily dose as shown in 
Equations  1 and  2.  When the hormone peptide was injected as  an aqueous 
solution for a period as brief as 4 days, the adrenal-stimulating  activity was 
found to be greatly reduced (Table VI). As would be expected, the adrenals of 
hypopsectomized rats respond with greater sensitivity, and a higher degree of 
precision can be obtained with them than with those of normal animals. It may 
be seen in Table II, that within 4 days a daily dose of approximately 1 I.~. of 
a-corticotropin will elicit an increase of 100 per cent in the adrenal weight of 
hypopsectomized rats. This increase may be employed as a routine procedure for 
the assay of corticotropin preparations. 
Theobservations that havebeen made to the effect that in the ovariectomized- 
hypophysectomized female rat a-corticotropin  induces deciduoma formation 
whereas in the castrated-hypophysectomized male rat it stimulates the growth 
of the ventral prostate as evidenced by the histological  changes illustrate the 
difficulties that may be encountered in assaying the anterior pituitary hormones 
through their effects on their respective target organs.  Earlier investigations, 
and the concepts stemming from them, require more careful interpretation in 
the light of presently accruing knowledge concerning  the ability of the adrenal 
cortex and gonads to secrete a considerable array of steroid compounds, some 
of which may be estrogenic,  progestogenic,  or androgenic.  Furthermore,  the 
fact that various steroids elaborated in the same organ or different organs may 
operate together antagonistically or synergistically renders extremely difficult 
the quantitation of such end results as interruption of the estrous cycle, vaginal 
cornification  or mucification,  progestational proliferation or deciduoma forma- 
tion in the uterus, various stages of mammary growth, and many other mani- 
festations. A good example of this difficulty is furnished by the careful quantita- 
tive work on the synergistic and antagonistic action of steroids done by Hisaw 
and Velardo (57,  58)  in the course of their studies on deciduoma formation. 
Hence,  it  is not surprising  that  these  investigators  (59)  have  subsequently 
demonstrated that ACTH inhibits progesterone-induced deciduoma formation, 
a finding entirely in disagreement with our data reported herein and also those 
previously published  (43).  This  discrepancy  was  described  by Hisaw and 
Velardo themselves (59) as probably only apparent and not real, since different 
degrees of adrenal  stimulation  were involved,  theirs  being  "moderate"  and 
ours "grossly exaggerated," at least in cases positive for deciduoma formation. 
It is likely that in our experiments the adrenals under the stimulation of a- 
corticotropin secreted progestogen in  amounts  that  overrode any inhibiting 
effects on the part of the cortisone-like  steroids that were concomitantly being 
secreted in amounts sufficient to obliterate the thymus. 
It is now beyond any doubt that the melanocyte-stimulating activity repre- 
sents one of the intrinsic biological properties of the a-corticotropin molecule. LI  ET  AL.  355 
When the activity of a-corticotropin is compared with that of the pure  MSH 
peptide isolated from the posterior lobes of pituitary glands (29, 60), it may be 
estimated that the former is about 1/100th as potent as the latter. Preparations 
of corticotropin A from pig glands have also been shown to possess melanocyte- 
stimulating activity (61, 62). As a structural consideration, it is of interest to 
note that a portion of the amino acid sequence in the MSH molecule (29, 63) is 
closely related to a sequence found in all corticotropin preparations (3, 62, 54), 
as follows: 
.... 
It is very probable that the melanocyte-stimulating activity of corticotropins 
can be attributed to the presence of this amino acid sequence in the hormone 
TABLE XV 
Erytkropoiet4x Activity o] c~-Cort~otropin in H ypopkysev¢omized Rats 
Daffy 
dose 
0 
5 
10 
25 
50 
No. of 
rats 
6 
6 
5 
6 
6 
Body weight 
75 4-  1.2" 
77 4-  1.0 
75 4-  1.0 
76 4-  1.0 
72 4-  1.0 
Hematocrit 
determination 
~ey c~t 
27.7  4-  1.2 
30.6 4-  1.3 
37.2  4-  1.0 
48.4 4-  2.1 
43.5  4-  1.3 
Total red cell 
volume/lO0 gin. 
B.W. 
3. 
1.43 4-  .02 
1.52  4-  .04 
1.88  4-  .04 
2.18  4-  .04 
2.11  4-  .03 
Adrenal 
mg. 
6.0 -4- 0.3 
8.5  4-  1.0 
11.5 4- 0.9 
25.3  4- 3.0 
35.0 4-  2.0 
Thymus 
mg. 
814-5 
82 4-  7 
<50 
Depleted 
Depleted 
* Mean 4- standard error. 
molecule. The final proof of this assumption  must await the synthesis of this 
peptide. 
Melanocyte stimulation is not the only function of a-corticotropin in the 
absence of adrenal glands. Recent studies of Menkin (65) have shown that the 
hormone peptide exerts the direct local effect of repressing the increased capil- 
lary permeability of an inflammed area in adrenalectomized rats.  Moreover, 
the adipokinetic activity of a-corticotropin herein reported can be discerned in 
adrenalectomized animals maintained with corticoid therapy. This points up a 
misconception that has been prevalent, arising from the name originally coined 
for the  major biological activity of the  substance;  i.e.,  adrenocorticotropic 
hormone. It has been assumed for a  long time that any ACTH preparation 
which can elicit a biological function in adrenalectomized animals is contami- 
nated with some active component(s) other than the ACTH itself. However, 
the  observations  discussed  above  clearly demonstrate  that  a-corticotropin, 
which is known to be pure (1, 2) and whose chemical structure has  been elu- 356  CORTICOTROPINS.  X 
cidated  (3), can exercise physiological functions without  the participation  of 
the adrenal gland. Similar confusion arising from terminology has recently been 
discussed in connection with pituitary growth hormone (66). 
In  addition  to  the  various  biological  functions  that  can  be exercised  by 
a-corticotropin, as reported herein, it has been demonstrated that the hormone 
is very potent as an  erythropoietic  factor, 7 according  to assay by  the Fe  59- 
labelled cell dilution method in hypophysectomized rats (67). As can be seen in 
Table XV, a daily dose of 25 ~g. of a-corticotropin administered to the hypophy- 
sectomived animals is capable of elevating the total red cell volume from 1.43 
ml. per 100 gln. of body weight, to 2.18 ml., a level identical with that found in 
normal rats (68). It may be further noted that the erythropoietic activity of the 
hormone increases with the dosage, reaching a maximum at a daily dose of 25 
#g. There appears to be some indication of an inhibition of this increment in red 
cell volume at the higher dose levels. Whether or not the adrenal cortex is es- 
sential for the erythropoietic activity of a-corticotropin  remains to be investi- 
gated. 
The same animals that were used for the determination of the erythropoietic 
activity (Table XV) were also tested for the calorigenic response to the graded 
doses of a-corticotropin.S Whereas the hypohysectomized control animals had a 
standard metabolic rate of 19 cal./re. ~ hr., after 12 days of injection all animals 
receiving daily doses of ~=corticotropin of 10/~g.  or more showed a significant 
elevation in this rate.  Thus at a daily dose of 10 ~g., the rate was 24.4; at 25 
~g., 31.1; and at 50 #g., 36.9 cal./re. 2 hr.  The corresponding rate for normal 
animals was found to be 41.8. 
Finally, a few words may be said about the biological activity of the hormone 
in  human  subjects.  Two  groups  of investigators  (69,  70)  have  carded  out 
metabolic investigations with a-corticotropin in man; both groups have shown 
that  the hormone peptide is active in stimulating  human adrenals.  Forsham 
et al. (69), reported that when a-corticotropin was assayed in man on the basis 
of steroidogenesis elicited by intravenous injections, an activity equivalent to 
150 I.U. per rag. of the peptide was obtained. 
SUMMARY 
Purified a-corticotropin has been reported to exercise the following biological 
effects: (c~) stimulation of the adrenal glands in normal and hypophysectomized 
rats,  (b) production of blood eosinopenla in hypophysectomized rats, (c) main- 
tenance of muscle glycogen in hypophysectomized rats, (d) inhibition of growth- 
promoting activity of somatotropin, (e) stimulation of melanocytes in the skin 
of frogs, (f)  mobilization  of fat into  the liver of fasted mice,  (g)  stimulation 
It is a pleasure to acknowledge, with thanks, the work of Drs. M. E. Simpson and A. N. 
Contopoulos on the assay of the erythropoietic activity of a-corticotropin. 
s We are indebted to Dr. E. Evans for these determinations. Full details will be published 
elsewhere (Evans, E., Simpson, M. E., and Contopoulos, A. N., Endocrinology, in press). LI ET AL.  357 
of the accessory sex glands of castrated-hypophysectomized male rats, (k) in- 
duction of deciduoma formation in hypophysectomized-oophorectomized rats, 
and  (i)  elevation of  the total red cell volume in hypophysectomized rats. a- 
Corticotropin has also been shown for the first time to act in synergism with 
lactogenic hormone as an essential galactopoietic hormone. 
The ability of a-corticotropin to elicit biological responses in the absence of 
the adrenal cortex is discussed. 
This work was supported in part by grants from the National Institutes of Health of the 
United States Public Health Service (Grant No. RG 4097), and the Albert and Mary Lasker 
Foundation. The authors wish to acknowledge  the able assistance of Charles W. Jordan, 
Winifred Lilly, Peggy Woodward, and Ruth E. Johnson, during the course of this investi- 
gation. 
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EXPLANATION OF PLATES 
P~  29 
FIG. 1. Hypophysectomized control. Hematoxylin and  eosln.  X  i6 
FIG. 2. Hypophysect0mized control. The juncti0nal , lipide-free  zone between the 
zona glomemlos& and zona fascicui~ta is composed O  f atrophic cells which have scanty 
cytoplasm andpyknotic nuclei as compared with the cells on either side. Hematoxylin 
and eosin.  X  110. 
FIG. 3. Hypophysectomized rat treated with 5/~g. of a-corticotropin, ttematoxylin 
and eosin.  X  16. 
FrG. 4. Higher magnification of Fig. 3. The cortical cells of all zones exhibit nuclear 
and cytoplasmic restitution. Some of the sinusoids  are dilated.  X  110. 
FIG. 5. Hypophysectomized rat treated with 30/~g. of a-corticotropin. Hematoxylin 
and eosin.  X  16. 
FIG. 6. Higher magnification of Fig. 5. The adrenal cortical cells are larger than those 
of rats treated with 5/~g. of ~-corticotropin. The sinusoids,  likewise, are dilated to a 
greater degree;  ×  110. 
FIG. 7. Hypophysectomized control. The lipide-free zone between the zona glomem- 
losa and zona fasciculata appears as a distinct pale area. Oil-red O and hematoxylin. 
X49. 
FIG. 8. Hypophysectomized rat treated with 5/~g. of ~-corticotropin. Lipide has 
been deposited in the junctional zone. The entire cortex shows an increased  amount 
of lipide;  X  49. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL.  105  PLATE 29 
(Li eta/.: Corticotropins. X) PLATE 30 
FIGS. 9 a and 9 b. Ventral prostate of the Long-Evans rat, operated at 44  days  of 
age and sacrificed at 55  days. Hematoxylin and  eosin.  )<  560. 
FIG. 9 a.  Hypophysectomized-castrated male rat injected with  saline;  weight  of 
prostate, 11.2 rag. 
Fla. 9 b. Hypophysectomized-castrated male rat injected with a daily dose 6~ 22.5 
~g. of a-corticotropin for 10 days; weight of prostate, 15.2 rag. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL  105  PLATE  30 
(Li et al. : Corticotropins. X) 